(Q54149984)

25 May 2018

title

Non-steroidal anti-inflammatory therapy for bronchial asthma. (English)

1 reference

25 May 2018

0 references

0 references

A S Banner

1

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

25 May 2018

number of pages

3

1 reference

inferred from page(s)

published in

The Lancet

1 reference

25 May 2018

volume

351

1 reference

25 May 2018

issue

9095

1 reference

25 May 2018

page(s)

5-7

1 reference

25 May 2018

Anti-inflammatory therapy for asthma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978098-3

7 January 2021

New insights into the pathogenesis and management of steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978098-3

7 January 2021

Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978098-3

7 January 2021

Trial of cyclosporin in corticosteroid-dependent chronic severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978098-3

7 January 2021

An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978098-3

7 January 2021

An evaluation of colchicine as an alternative to inhaled corticosteriods in moderate asthma. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978098-3

7 January 2021

Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2978098-3

7 January 2021

10.1016/S0140-6736(05)78098-3

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018